Christopher Kirk

President & Chief Scientific Officer, Co-Founder

Christopher Kirk, Ph.D. is the co-founder, President, and Chief Scientific Officer and is an immunologist and tumor biologist by training. Prior to founding Kezar, he was the Vice President of Research at Onyx Pharmaceuticals where he played a key leadership role in the discovery and development of 2 proteasome inhibitors, including carfilzomib ...


Roles at Kezar Life Sciences

  • President & Chief Scientific Officer, Co-Founder

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.